Skip to main content
. 2021 Jan 6;11(1):31. doi: 10.3390/jpm11010031

Figure 6.

Figure 6

Evaluation of both miRNAs’ plasma expression as staging biomarkers. (a) Relative quantification showed that there was increased expression of both miRNAs in plasma samples from women with breast cancer (BC) vs. the control group. (b) Relative quantification showed that there was increased expression of both miRNAs in plasma samples from women with advanced stage vs. early/intermediate, benign breast conditions (BBC) group and controls. Significant value in Kruskal–Wallis and Dunn’s post test (±SEM - standard error of the mean; ** p < 0.01; *** p < 0.01).